| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |